HUANG, YE,KOSKI, ANDREW, K.,PETERSON, KATHERINE, E.
申请号：
PH12016500042
公开号：
PH12016500042A1
申请日:
2016.01.06
申请国别(地区):
PH
年份:
2016
代理人:
摘要：
The present disclosure relates to: (a) stabilized pharmaceutical dosage forms comprising atrasenstan, or a pharmaceutically acceptable salt thereof, and, optionally, another therapeutic agent； (b) methods of using such pharmaceutical dosage forms to treat nephropathy, chronic kidney disease, and/or other conditions； (c) kits comprising such pharmaceutical dosage forms and, optionally, a second pharmaceutical dosage form comprising another therapeutic agent； (d) methods for the preparation of such pharmaceutical dosage forms； and (e) pharmaceutical dosage forms prepared by such methods.
